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ABSTRACT
Background and Objectives: EUS‑guided pelvic abscess drainage (EUS‑PAD) is a procedure that utilizes an echoendoscope
to visualize an area of interest for needle insertion and placement of a stent, catheter, or both for drainage of the target
abscess. The aim of this study was to perform a systematic review and meta‑analysis for the safety and efficacy of EUS‑PAD.
Materials and Methods: We conducted a comprehensive search of several databases and conference proceedings including
PubMed, EMBASE, Google Scholar, MEDLINE, SCOPUS, and Web of Science databases (earliest inception to February
2020). The primary outcomes for this study were the technical and clinical success of EUS‑PAD. The secondary outcomes
assessed for this study were adverse events of the procedure and subgroup analysis of individual adverse events. Results:
Eight studies with a total of 135 patients combined were included in our analysis. The rate of technical success was 100% and
the calculated pooled rate of clinical success was 92% (95% confidence interval [CI]: 87%, 98%; P = 0.31; I2 = 15%). The
calculated pooled rate of adverse events was 9.4% (±17.9%), with stent migration (5.5 ± 18.06%) being the most common
adverse event. Conclusion: EUS‑PAD offers a viable alternative that can minimize the need for surgical intervention in
the drainage of pelvic abscesses. EUS‑PAD has also demonstrated long‑term clinical success with an acceptable rate of
complications.
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INTRODUCTION
Pelvic abscesses may arise from several etiologies
including surgery (e.g., low anterior resection), perforation
of pelvic viscera, diverticulitis, appendicitis, ischemic
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colitis, inflammatory bowel disease, or from pelvic
inflammatory disease, among other causes. [1,2] Pelvic
abscesses are associated with significant morbidity
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and mortality. [3] Management, per the Infectious
Diseases Society of America and Surgical Infection
Society, includes a combination of medical and surgical
therapies, of which drainage of the abscess is of utmost
importance to obtain source control. [4,5] Currently,
computed tomography (CT)‑guided percutaneous
drainage (PCD) is the preferred method for drainage
of pelvic abscesses. [5] Other modalities include
ultrasound (US)‑guided transrectal drainage and surgical
drainage.
Limitations of PCD and US procedures include, but are
not limited to, catheter dislodgment, patient discomfort,
and limited access points of fluid drainage secondary to
the complexity of pelvic anatomy.[1,6] EUS‑guided pelvic
abscess drainage (EUS‑PAD) is an alternative minimally
invasive procedure which can be used for drainage of
pelvic abscesses. With EUS, one can usually target a
pelvic abscess since most fluid collections are located
close to the rectum and left colon.[7]
EUS‑PAD was first described by Giovannini et al. in
2003.[8] The procedure utilizes an echoendoscope to
visualize an area of interest for needle insertion and
placement of a stent, catheter, or both for drainage of
the target abscess.[6] With utilization of this procedure,
patients can achieve shorter durations of hospital stay
leading to lower costs and a bedside procedure can be
performed in critically ill patients if necessary.[6]

drainage of pelvic abscesses [Supplementary Figure 1].[9]
The bibliographic section of the selected articles, as
well as the systematic and narrative articles on the topic,
was manually searched for additional relevant articles.

Study selection

We included studies that evaluated the clinical efficacy and
adverse events of EUS‑PAD. Studies were included as long
as they provided data needed for the analysis. Exclusion
criteria were as follows: (1) studies using other techniques
of PAD other than EUS, (2) studies performed in the
pediatric population (patient age <18 years) or among
prisoners, (3) studies with <5 patients, and (4) studies not
published in the English language.
We excluded multiple studies that reported on the same
cohort. In case of overlapping cohorts, we included the
most appropriate study.

Data abstraction and quality assessment

Two authors independently assessed (BD and SS) and
performed quality assessment independently, and any
differences were resolved with the help of the third
author (YN).

The aim of this study was to perform a systematic
review and meta‑analysis for the safety and efficacy of
EUS‑PAD.

Data collection was recorded as number of reported
events (n) out of the total number of patients (N)
from each study. The collected data were treated akin
to single group cohort studies, and therefore, we used
the Newcastle–Ottawa scale (NOS) to assess the quality
of studies. [10] This quality score is comprised of 3
categories and 8 questions, the details of which are
provided in Supplementary Table 1.

METHODS

Outcomes assessed

Data sources

We performed a search of multiple databases including
MEDLINE, EMBASE, Google Scholar, Cochrane, and
Web of Science databases (earliest inception to February
2020). The literature search utilized a combination
of keywords “EUS,” “endoscopic” and “ultrasound,”
“pelvic,” “abscess,” and “drainage.” This search was
carried out by two authors (BD and YN) who reviewed
the titles and abstracts individually and excluded studies
that did not meet the inclusion criteria. We conducted
the search and narrowed down the final studies as
per the Preferred Reporting Items for Systematic
Reviews and Meta‑Analyses guidelines, as well as the
Meta‑Analysis of Observational Studies in Epidemiology
guidelines to identify studies reporting on EUS‑guided
186

The primary outcomes for this study were the technical
and clinical success of EUS‑PAD. The secondary
outcomes assessed for this study include adverse events
of the procedure and subgroup analysis of individual
adverse events.

Definitions

Technical success was defined as the successful access
and drainage of the abscess via EUS. Clinical success
was defined as symptom resolution with complete
resolution of abscess on subsequent imaging performed
1–4 weeks after the procedure.

Statistical analysis

We used meta‑analysis techniques to calculate the pooled
estimates for each outcome of interest following the
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methods suggested by DerSimonian and Laird using
the random‑effects model where appropriate. [17] In
several instances in the adverse event data, values of
0 occurred. In these instances, we avoided inadvertently
adding positive bias to the outcomes by writing syntax
to calculate weighted summary statistics. In this way,
we preserved the integrity of the actual data values and
avoided possible biases in reporting the outcomes. We
assessed heterogeneity between study‑specific estimates
using Cochran’s Q statistical test for heterogeneity and
the I2 statistics.[18,19] In this, values of <30%, 30%–60%,
61%–75%, and >75% were suggestive of low, moderate,
substantial, and considerable heterogeneity, respectively.[20]
Publication bias was ascertained qualitatively by visual
inspection of funnel plot and quantitatively by the Luis
Furuya-Kanamori (LFK) test; further, the extent of
potential bias was ascertained utilizing the Doi plot.[21]
Sensitivity analysis was conducted in instances of potential
bias by recalculating all statistics after removal of studies
leading to LFK asymmetry; if removal of the study
impacted estimates, the study was removed from the
final analysis. All meta‑analyses were performed using
MetaXL software (v. 5.3; EpiGear International, Sunrise
Beach, Queensland, Australia). The weighted correlation
was calculated using the <wtd.cor> script in the “weight”
package, with bootstrapped P values calculated with
n = 10,000 iterations, using R (v 3.6.1; Vienna, Austria).
Finally, we estimated lower and upper confidence limits for
clinical success using the Clopper–Pearson exact method
implemented in the <PropCI> package, also using R.
RESULTS

Search results and population characteristics

From an initial group of 173 studies, 8 studies reported
data regarding the use of EUS‑PAD. Multiple studies
with overlapping cohorts were found, and the most
appropriate ones were included in the final analysis. The
majority of the patient population were male (55.9%

reported in 7 studies), and the mean age mentioned
in 7/8 studies was 54.22 years. Seventy percent of
the abscesses were postsurgical and 30% of the
abscesses were related to medical conditions, primarily
diverticulitis. The mean abscess size was 63.32 mm,
with abscesses being perirectal in 83.7% of the cases
and pericolonic in the remainder of the cases.
Drainage was performed with double‑pigtail plastic
stents in 100 patients (74%) and lumen‑apposing
metal stent (LAMS) in 23 patients (17%). Twelve
patients (9%) underwent needle aspiration only. Table 1
describes the characteristics of the included studies. The
schematic diagram of study selection is illustrated in
Supplementary Figure 1.

Characteristics and quality of included studies

The analysis included 8 independent cohort studies,
with a total of 135 patients. There were 2 multicenter
studies, no population‑based studies, and 6 single‑center
studies included in our final analysis. Two studies
had more than 30 patients, 4 studies had more than
10 patients, and 2 studies had less than 10 patients.
Seven studies were published in manuscript form, and
one study was published in abstract form. All of the
included studies had clear information reported on the
technical and clinical success of EUS‑PAD. Table 1
describes the characteristics of the included studies.
Quality assessment was performed with the help of the
NOS scale. Seven studies were of good quality, and
one study was of poor quality. The details of quality
assessment are shown in Supplementary Table 1.

Meta‑analysis outcomes

Primary outcomes
The rate of technical success was 100% and the
calculated pooled rate of clinical success was 92% (95%
confidence inter val [CI]: 87%, 98%; P = 0.31;

Table 1. Characteristics of the included studies
Study name

Year

Country

Type of
study

Single/
multicenter

Manuscript
or abstract

Number of
patients

Mean
age

Male

Female

Giovannini et al.[8]
Hadithi and Bruno[13]
Mudireddy et al.[16]
Poincloux et al.[15]
Puri et al.[11]
Ramesh‑a et al.[12]
Ramesh‑b et al.[12]
Ratone et al.[14]
Manvar et al.[22]

2003
2014
2018
2017
2010
2013
2013
2015
2017

France
The Netherlands
USA
France
India
USA
USA
France
USA

Prospective
Retrospective
Retrospective
Retrospective
Retrospective
Retrospective
Retrospective
Retrospective
Retrospective

Single center
Single center
Multicenter
Multicenter
Single center
Single center
Single center
Single center
Single center

Manuscript
Manuscript
Manuscript
Manuscript
Manuscript
Manuscript
Manuscript
Manuscript
abstract

12
8
8
37
14
11
27
7
11

67
55.5
‑
61.4
42
55.5
51
50
51.36

9
6
‑
20
11
5
13
4
3

3
2
‑
17
3
6
14
3
8
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I2 = 15%). Figure 1 shows the forest plot for clinical
success of EUS‑PAD.
Secondary outcomes
The calculated pooled rate of adverse events was
9.4% (±17.9%), with stent migration (5.5 ± 18.06%)
being the most common adverse event. Table 2
describes the adverse events in different studies.

Validation of meta‑analysis results

Sensitivity analysis
To assess whether any one study had a dominant effect
on the meta‑analysis, we excluded one study at a time
and analyzed its effect on the main summary estimate.
Based on this analysis, no single study significantly
affected the outcome or the heterogeneity.

Heterogeneity

Based on Q statistics and I2 analysis for heterogeneity,
low heterogeneity was noted in the analysis of clinical
success of  EUS‑PAD.

Publication bias

Based on visual inspection of the funnel plot and the Doi
plot, as well as quantitative measurement based on the
LFK test, there was evidence of asymmetry and hence
potential publication bias. Sensitivity analysis by removal
of asymmetric studies revealed the impact of the possible

publication bias, but this did not lead to a statistical
change in the calculated estimate or the conclusion of this
meta‑analysis. However, it should be noted that the ability
to detect potential publication bias is limited.
DISCUSSION
Our study demonstrates that EUS‑PAD is an effective
and minimally invasive treatment option for the
management of pelvic abscesses. This meta‑analysis
shows that EUS‑PAD has high technical and clinical
success rates with low rates of adverse events.
The rate of technical success in our meta‑analysis was
100%. The straightforward nature of the procedure
allows it to be an effective alternative to more invasive
approaches, such as image‑guided PCD or surgery.[2]
The clinical success rate of EUS‑PAD, according to
our analysis, was also high. Clinical success was related
to technical success, indicating the importance of
technically successful procedure. The etiology of the
abscess also appeared to be a major determinant
in treatment success. In a study by Ramesh et al.,
diverticular abscesses had significantly lower treatment
success rates than abscesses of other etiologies.[12] It is
hypothesized that the often multiloculated and highly
viscous nature of diverticular abscesses resulted in
higher rates of treatment failure.[12]

Figure 1. Forest plot showing clinical success of   EUS-PAD

Table 2. Adverse events of EUS pancreatic drainage
Study name

Year

Total adverse events

Bleeding

Perforation

Abdominal pain

Stent migration

Others

Giovannini et al.[8]
Hadithi and Bruno[13]
Mudireddy et al.[16]
Poincloux et al.[15]
Puri et al.[11]
Ramesh‑a et al.[12]
Ramesh‑b et al.[12]
Ratone et al.[14]
Manvar et al.[22]

2003
2014
2018
2017
2010
2013
2013
2015
2017

3
6
‑
3
1
0
0
0
0

0
0
‑
0
0
0
0
0
0

0
0
‑
1
0
0
0
0
0

1
0
‑
0
0
0
0
0
0

0
6
‑
1
0
0
0
0
0

2
1
‑
1
1
0
0
0
0
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Our study found an adverse event rate of 9.4%. This
is comparable to outcomes of US/CT‑guided PAD
in which the adverse event rate ranges from 5.6% to
10%.[23‑25] EUS provides accurate representations of the
fluid collections, organs, and vessels, which allows for
accurate transmural drainage while minimizing major
complications, such as bleeding and perforation. In our
meta‑analysis, only one perforation was noted, and there
were no cases of major bleeding. Perforation occurred,
according to the study by Poincloux et al., in a patient
with a diverticular abscess.[15] This is consistent with the
overall worse outcomes among patients with diverticular
abscesses as noted by Ramesh et al.[12] Several minor
complications, such as stent migration, abdominal pain,
or rectal discomfort, also occurred. There were no
procedure‑related deaths.
EUS‑PAD is performed by various and nonstandardized
methods, such as needle aspiration, aspiration with or
without tract dilation, and placement of plastic and/or
LAMS.[11] Stents are utilized to maintain tract patency
and to reduce the risk of premature tract closure. Stent
placement is limited by the distance of the abscess
to the rectal wall. If the distance is >20 mm, stent
placement is often not technically feasible with currently
available stents.[8,14] In the studies using double‑pigtail
plastic stents, one or two stents were placed. In the
studies using LAMS, a single LAMS was placed. The
decision to place one or two stents is determined by
the operator and individualized to the patient’s needs
and clinical situation. [12,26] Historically, plastic stents
were utilized. However, LAMS has been used in more
recent studies.[15,16,22] Of the four patients treated with
LAMS in the study by Poincloux et al., one developed
a recurrence; another with a diverticular abscess
had a perforation. [15] Transrectal drainage catheters
can also be utilized in conjunction with stenting to
prevent obstruction for patients with larger abscesses
(>8 cm).[12,26] However, these have been associated with
rectal discomfort and are not clearly crucial for abscess
resolution.[11,13,15]
Recurrence occurred in 6 patients (4%). Giovannini
et al. and Puri et al. reported higher rates of recurrence
in patients who only underwent aspiration without
dilation or stenting. Three out of six patients who had
recurrence underwent aspiration only. These authors
hypothesized that further interventions, such as stenting
and dilatation, could have reduced the likelihood of
recurrence.[8,11] Overall, careful consideration should be
taken with regard to the size, etiology, and maturity of

the abscess when considering stent placement. Smaller
abscesses appear to be amenable to simple aspiration,
whereas larger abscesses benefit from stent placement.
There were several limitations to this meta‑analysis. The
majority of the studies were retrospective in nature.
Most of the studies were also undertaken in single
centers with experienced advanced endoscopists, and
the results may not be generalizable to the broader
endoscopic community. Techniques utilized were
individualized between different providers including the
size, number, and methods in which stents were placed.
Finally, no direct comparison was made to the other
techniques used to drain pelvic abscesses (PCD or a
surgical approach).
CONCLUSION
EUS‑PAD offers a viable alternative that can minimize
the need for surgical intervention in the drainage
of pelvic abscesses. It is best suited for unilocular
abscesses with a mature wall that allows for the creation
of a fistula to permit drainage.[2,8] Smaller abscesses < 4
cm can be usually treated without endoscopic
intervention. [2] Considerations should be taken for
abscesses of diverticular etiology as higher rates of
complications were seen.[12] Finally, EUS‑PAD should
be strictly avoided in patients with ascites or if the
abscess is >20 mm from the bowel lumen.[2] EUS‑PAD
has also demonstrated long‑term clinical success with
an acceptable rate of complications. However, more
well‑conducted randomized controlled trials are needed
to establish its role as an alternative to imaging‑guided
abscess drainage.

Supplementary materials

Supplementary information is linked to the online
version of the paper on the Endoscopic Ultrasound
website.
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Supplementary Table 1. Quality assessment of the study with Newcastle‑Ottawa Scale
Study

Year

Giovannini et al.[8]
Puri et al.[11]
Ramesh et al.[12]
Hadithi and Bruno[13]
Ratone et al.[14]
Poincloux et al.[15]
Manvar et al.[14]
Mudireddy et al.[16]

2003
2010
2013
2014
2015
2017
2017
2018

Number of
patients

Selection

Newcastle‑Ottawa Scale
Comparability

Outcome

12
14
11
35
7
37
11
8

**
***
***
**
**
**
**
***

*
*
**
*
*
*
*
*

**
***
***
***
***
***
*
***

SCREENING

IDENTIFICATION

NOS score consists of 3 categories: 1) Selection-included 4 questions and maximum one star per question could be awarded 2) Comparability-included 1 question
and maximum two stars could be awarded and, 3) Exposure- included 3 questions and maximum one star per question could be awarded. Good quality study
was defined as 3 or 4 stars in selection domain and 1 or 2 stars in comparability domain and 2 or 3 stars in outcome domain. Fair quality study was defined as 2
stars in selection domain and 1 or 2 stars in comparability domain and 2 or 3 stars in outcome domain. Poor quality study was defined as 0 or 1 star in selection
domain and 0 stars in comparability domain and 0 or 1 star in outcome domain.

Databases from their inception through
February, 2020

Total no. of articles found on search in
PubMed, Embase, and others (n = 173)

Titles and abstracts screened (n = 25)

ELIGIBILITY

Abstracts were reviewed (n = 11)

Excluded (n = 148)
• Duplicates
• Case reports
• Other procedures

Excluded (n = 3)
• Cohort overlap
Excluded (n = 14)
• Review articles
• Did not meet
inclusion criteria

INCLUDED

Full text screened for eligibility (n = 8)

Studies for systematic review (n = 8)

Supplementary Figure 1. Study selection process in accordance with
preferred reporting items for systematic reviews and meta-analysis
statement

